(215 ILCS 134/5)
Sec. 5.
Health care patient rights.
(a) The General Assembly finds that:
(1) A patient has the right to care consistent with |
| professional standards of practice to assure quality nursing and medical practices, to choose the participating physician responsible for coordinating his or her care, to receive information concerning his or her condition and proposed treatment, to refuse any treatment to the extent permitted by law, and to privacy and confidentiality of records except as otherwise provided by law.
|
|
(2) A patient has the right, regardless of source of
|
| payment, to examine and to receive a reasonable explanation of his or her total bill for health care services rendered by his or her physician or other health care provider, including the itemized charges for specific health care services received. A physician or other health care provider has responsibility only for a reasonable explanation of those specific health care services provided by the health care provider.
|
|
(3) A patient has the right to timely prior notice of
|
| the termination whenever a health care plan cancels or refuses to renew an enrollee's participation in the plan.
|
|
(4) A patient has the right to privacy and
|
| confidentiality in health care. This right may be expressly waived in writing by the patient or the patient's guardian.
|
|
(5) An individual has the right to purchase any
|
| health care services with that individual's own funds.
|
|
(b) Nothing in this Section shall preclude the health care plan from
sharing information for
plan quality assessment and improvement purposes as required by Section 80.
(Source: P.A. 91-617, eff. 1-1-00.)
|
(215 ILCS 134/10)
Sec. 10. Definitions.
"Adverse determination" means a determination by a health care plan under
Section 45 or by a utilization review program under Section
85 that
a health care service is not medically necessary.
"Clinical peer" means a health care professional who is in the same
profession and the same or similar specialty as the health care provider who
typically manages the medical condition, procedures, or treatment under
review.
"Department" means the Department of Insurance.
"Emergency medical condition" means a medical condition manifesting itself by
acute symptoms of sufficient severity, regardless of the final diagnosis given, such that a prudent
layperson, who possesses an average knowledge of health and medicine, could
reasonably expect the absence of immediate medical attention to result in:
(1) placing the health of the individual (or, with |
| respect to a pregnant woman, the health of the woman or her unborn child) in serious jeopardy;
|
|
(2) serious
impairment to bodily functions;
(3) serious dysfunction of any bodily organ
or part;
(4) inadequately controlled pain; or
(5) with respect to a pregnant woman who is having
|
|
(A) inadequate time to complete a safe transfer
|
| to another hospital before delivery; or
|
|
(B) a transfer to another hospital may pose a
|
| threat to the health or safety of the woman or unborn child.
|
|
"Emergency medical screening examination" means a medical screening
examination and
evaluation by a physician licensed to practice medicine in all its branches, or
to the extent permitted
by applicable laws, by other appropriately licensed personnel under the
supervision of or in
collaboration with a physician licensed to practice medicine in all its
branches to determine whether
the need for emergency services exists.
"Emergency services" means, with respect to an enrollee of a health care
plan,
transportation services, including but not limited to ambulance services, and
covered inpatient and outpatient hospital services
furnished by a provider
qualified to furnish those services that are needed to evaluate or stabilize an
emergency medical condition. "Emergency services" does not
refer to post-stabilization medical services.
"Enrollee" means any person and his or her dependents enrolled in or covered
by a health care plan.
"Health care plan" means a plan, including, but not limited to, a health maintenance organization, a managed care community network as defined in the Illinois Public Aid Code, or an accountable care entity as defined in the Illinois Public Aid Code that receives capitated payments to cover medical services from the Department of Healthcare and Family Services, that establishes, operates, or maintains a
network of health care providers that has entered into an agreement with the
plan to provide health care services to enrollees to whom the plan has the
ultimate obligation to arrange for the provision of or payment for services
through organizational arrangements for ongoing quality assurance,
utilization review programs, or dispute resolution.
Nothing in this definition shall be construed to mean that an independent
practice association or a physician hospital organization that subcontracts
with
a health care plan is, for purposes of that subcontract, a health care plan.
For purposes of this definition, "health care plan" shall not include the
following:
(1) indemnity health insurance policies including
|
| those using a contracted provider network;
|
|
(2) health care plans that offer only dental or only
|
|
(3) preferred provider administrators, as defined in
|
| Section 370g(g) of the Illinois Insurance Code;
|
|
(4) employee or employer self-insured health benefit
|
| plans under the federal Employee Retirement Income Security Act of 1974;
|
|
(5) health care provided pursuant to the Workers'
|
| Compensation Act or the Workers' Occupational Diseases Act; and
|
|
(6) except with respect to subsections (a) and (b) of
|
| Section 65 and subsection (a-5) of Section 70, not-for-profit voluntary health services plans with health maintenance organization authority in existence as of January 1, 1999 that are affiliated with a union and that only extend coverage to union members and their dependents.
|
|
"Health care professional" means a physician, a registered professional
nurse,
or other individual appropriately licensed or registered
to provide health care services.
"Health care provider" means any physician, hospital facility, facility licensed under the Nursing Home Care Act, long-term care facility as defined in Section 1-113 of the Nursing Home Care Act, or other
person that is licensed or otherwise authorized to deliver health care
services. Nothing in this
Act shall be construed to define Independent Practice Associations or
Physician-Hospital Organizations as health care providers.
"Health care services" means any services included in the furnishing to any
individual of medical care, or the
hospitalization incident to the furnishing of such care, as well as the
furnishing to any person of
any and all other services for the purpose of preventing,
alleviating, curing, or healing human illness or injury including behavioral health, mental health, home health,
and pharmaceutical services and products.
"Medical director" means a physician licensed in any state to practice
medicine in all its
branches appointed by a health care plan.
"Person" means a corporation, association, partnership,
limited liability company, sole proprietorship, or any other legal entity.
"Physician" means a person licensed under the Medical
Practice Act of 1987.
"Post-stabilization medical services" means health care services
provided to an enrollee that are furnished in a licensed hospital by a provider
that is qualified to furnish such services, and determined to be medically
necessary and directly related to the emergency medical condition following
stabilization.
"Stabilization" means, with respect to an emergency medical condition, to
provide such medical treatment of the condition as may be necessary to assure,
within reasonable medical probability, that no material deterioration
of the condition is likely to result.
"Utilization review" means the evaluation of the medical necessity,
appropriateness, and efficiency of the use of health care services, procedures,
and facilities.
"Utilization review program" means a program established by a person to
perform utilization review.
(Source: P.A. 102-409, eff. 1-1-22; 103-426, eff. 8-4-23.)
|
(215 ILCS 134/15)
Sec. 15. Provision of information.
(a) A health care plan shall provide annually to enrollees and prospective
enrollees, upon request, a complete list of participating health care providers
in the
health care plan's service area and a description of the following terms of
coverage:
(1) the service area;
(2) the covered benefits and services with all |
| exclusions, exceptions, and limitations;
|
|
(3) the pre-certification and other utilization
|
| review procedures and requirements;
|
|
(4) a description of the process for the selection of
|
| a primary care physician, any limitation on access to specialists, and the plan's standing referral policy;
|
|
(5) the emergency coverage and benefits, including
|
| any restrictions on emergency care services;
|
|
(6) the out-of-area coverage and benefits, if any;
(7) the enrollee's financial responsibility for
|
| copayments, deductibles, premiums, and any other out-of-pocket expenses;
|
|
(8) the provisions for continuity of treatment in the
|
| event a health care provider's participation terminates during the course of an enrollee's treatment by that provider;
|
|
(9) the appeals process, forms, and time frames for
|
| health care services appeals, complaints, and external independent reviews, administrative complaints, and utilization review complaints, including a phone number to call to receive more information from the health care plan concerning the appeals process; and
|
|
(10) a statement of all basic health care services
|
| and all specific benefits and services mandated to be provided to enrollees by any State law or administrative rule.
|
|
(a-5) Without limiting the generality of subsection (a) of this Section, no qualified health plans shall be offered for sale directly to consumers through the health insurance marketplace operating in the State in accordance with Sections 1311 and
1321 of the federal Patient Protection and Affordable Care Act (Public Law 111-148), as amended by the federal Health Care and Education Reconciliation Act of 2010 (Public Law 111-152), and any amendments thereto, or regulations or guidance issued thereunder (collectively, "the Federal Act"), unless, in addition to the information required under subsection (a) of this Section, the following information is available to the consumer at the time he or she is comparing health care plans and their premiums:
(1) With respect to prescription drug benefits, the
|
| most recently published formulary where a consumer can view in one location covered prescription drugs; information on tiering and the cost-sharing structure for each tier; and information about how a consumer can obtain specific copayment amounts or coinsurance percentages for a specific qualified health plan before enrolling in that plan. This information shall clearly identify the qualified health plan to which it applies.
|
|
(2) The most recently published provider directory
|
| where a consumer can view the provider network that applies to each qualified health plan and information about each provider, including location, contact information, specialty, medical group, if any, any institutional affiliation, and whether the provider is accepting new patients. The information shall clearly identify the qualified health plan to which it applies.
|
|
In the event of an inconsistency between any separate written disclosure
statement and the enrollee contract or certificate, the terms of the enrollee
contract or certificate shall control.
(b) Upon written request, a health care plan shall provide to enrollees a
description of the financial relationships between the health care plan and any
health care provider
and, if requested, the percentage
of copayments, deductibles, and total premiums spent on healthcare related
expenses and the percentage of
copayments, deductibles, and total premiums spent on other expenses, including
administrative expenses,
except that no health care plan shall be required to disclose specific provider
reimbursement.
(c) A participating health care provider shall provide all of the
following, where applicable, to enrollees upon request:
(1) Information related to the health care provider's
|
| educational background, experience, training, specialty, and board certification, if applicable.
|
|
(2) The names of licensed facilities on the provider
|
| panel where the health care provider presently has privileges for the treatment, illness, or procedure that is the subject of the request.
|
|
(3) Information regarding the health care provider's
|
| participation in continuing education programs and compliance with any licensure, certification, or registration requirements, if applicable.
|
|
(d) A health care plan shall provide the information required to be
disclosed under this Act upon enrollment and annually thereafter in a legible
and understandable format. The Department
shall promulgate rules to establish the format based, to the extent
practical,
on
the standards developed for supplemental insurance coverage under Title XVIII
of
the federal Social Security Act as a guide, so that a person can compare the
attributes of the various health care plans.
(e) The written disclosure requirements of this Section may be met by
disclosure to one enrollee in a household.
(f) Each issuer of qualified health plans for sale directly to consumers through the health insurance marketplace operating in the State shall make the information described in subsection (a) of this Section, for each qualified health plan that it offers, available and accessible to the general public on the company's Internet website and through other means for individuals without access to the Internet.
(g) The Department shall ensure that State-operated Internet websites, in addition to the Internet website for the health insurance marketplace established in this State in accordance with the Federal Act and its implementing regulations, prominently provide links to Internet-based materials and tools to help consumers be informed purchasers of health care plans.
(h) Nothing in this Section shall be interpreted or implemented in a manner not consistent with the Federal Act. This Section shall apply to all qualified health plans offered for sale directly to consumers through the health insurance marketplace operating in this State for any coverage year beginning on or after January 1, 2015.
(Source: P.A. 103-154, eff. 6-30-23.)
|
(215 ILCS 134/25)
Sec. 25. Transition of services.
(a) A health care plan shall provide for continuity of care for its
enrollees as follows:
(1) If an enrollee's physician leaves the health care |
| plan's network of health care providers for reasons other than termination of a contract in situations involving imminent harm to a patient or a final disciplinary action by a State licensing board and the physician remains within the health care plan's service area, the health care plan shall permit the enrollee to continue an ongoing course of treatment with that physician during a transitional period:
|
|
(A) of 90 days from the date of the notice of
|
| physician's termination from the health care plan to the enrollee of the physician's disaffiliation from the health care plan if the enrollee has an ongoing course of treatment; or
|
|
(B) if the enrollee has entered the third
|
| trimester of pregnancy at the time of the physician's disaffiliation, that includes the provision of post-partum care directly related to the delivery.
|
|
(2) Notwithstanding the provisions in item (1) of
|
| this subsection, such care shall be authorized by the health care plan during the transitional period only if the physician agrees:
|
|
(A) to continue to accept reimbursement from the
|
| health care plan at the rates applicable prior to the start of the transitional period;
|
|
(B) to adhere to the health care plan's quality
|
| assurance requirements and to provide to the health care plan necessary medical information related to such care; and
|
|
(C) to otherwise adhere to the health care plan's
|
| policies and procedures, including but not limited to procedures regarding referrals and obtaining preauthorizations for treatment.
|
|
(3) During an enrollee's plan year, a health care
|
| plan shall not remove a drug from its formulary or negatively change its preferred or cost-tier sharing unless, at least 60 days before making the formulary change, the health care plan:
|
|
(A) provides general notification of the change
|
| in its formulary to current and prospective enrollees;
|
|
(B) directly notifies enrollees currently
|
| receiving coverage for the drug, including information on the specific drugs involved and the steps they may take to request coverage determinations and exceptions, including a statement that a certification of medical necessity by the enrollee's prescribing provider will result in continuation of coverage at the existing level; and
|
|
(C) directly notifies by first class mail and
|
| through an electronic transmission, if available, the prescribing provider of all health care plan enrollees currently prescribed the drug affected by the proposed change; the notice shall include a one-page form by which the prescribing provider can notify the health care plan by first class mail that coverage of the drug for the enrollee is medically necessary.
|
|
The notification in paragraph (C) may direct the
|
| prescribing provider to an electronic portal through which the prescribing provider may electronically file a certification to the health care plan that coverage of the drug for the enrollee is medically necessary. The prescribing provider may make a secure electronic signature beside the words "certification of medical necessity", and this certification shall authorize continuation of coverage for the drug.
|
|
If the prescribing provider certifies to the health
|
| care plan either in writing or electronically that the drug is medically necessary for the enrollee as provided in paragraph (C), a health care plan shall authorize coverage for the drug prescribed based solely on the prescribing provider's assertion that coverage is medically necessary, and the health care plan is prohibited from making modifications to the coverage related to the covered drug, including, but not limited to:
|
|
(i) increasing the out-of-pocket costs for the
|
|
(ii) moving the covered drug to a more
|
|
(iii) denying an enrollee coverage of the drug
|
| for which the enrollee has been previously approved for coverage by the health care plan.
|
|
Nothing in this item (3) prevents a health care plan
|
| from removing a drug from its formulary or denying an enrollee coverage if the United States Food and Drug Administration has issued a statement about the drug that calls into question the clinical safety of the drug, the drug manufacturer has notified the United States Food and Drug Administration of a manufacturing discontinuance or potential discontinuance of the drug as required by Section 506C of the Federal Food, Drug, and Cosmetic Act, as codified in 21 U.S.C. 356c, or the drug manufacturer has removed the drug from the market.
|
|
Nothing in this item (3) prohibits a health care
|
| plan, by contract, written policy or procedure, or any other agreement or course of conduct, from requiring a pharmacist to effect substitutions of prescription drugs consistent with Section 19.5 of the Pharmacy Practice Act, under which a pharmacist may substitute an interchangeable biologic for a prescribed biologic product, and Section 25 of the Pharmacy Practice Act, under which a pharmacist may select a generic drug determined to be therapeutically equivalent by the United States Food and Drug Administration and in accordance with the Illinois Food, Drug and Cosmetic Act.
|
|
This item (3) applies to a policy or contract that is
|
| amended, delivered, issued, or renewed on or after January 1, 2019. This item (3) does not apply to a health plan as defined in the State Employees Group Insurance Act of 1971 or medical assistance under Article V of the Illinois Public Aid Code.
|
|
(b) A health care plan shall provide for continuity of care for new
enrollees as follows:
(1) If a new enrollee whose physician is not a member
|
| of the health care plan's provider network, but is within the health care plan's service area, enrolls in the health care plan, the health care plan shall permit the enrollee to continue an ongoing course of treatment with the enrollee's current physician during a transitional period:
|
|
(A) of 90 days from the effective date of
|
| enrollment if the enrollee has an ongoing course of treatment; or
|
|
(B) if the enrollee has entered the third
|
| trimester of pregnancy at the effective date of enrollment, that includes the provision of post-partum care directly related to the delivery.
|
|
(2) If an enrollee elects to continue to receive care
|
| from such physician pursuant to item (1) of this subsection, such care shall be authorized by the health care plan for the transitional period only if the physician agrees:
|
|
(A) to accept reimbursement from the health care
|
| plan at rates established by the health care plan; such rates shall be the level of reimbursement applicable to similar physicians within the health care plan for such services;
|
|
(B) to adhere to the health care plan's quality
|
| assurance requirements and to provide to the health care plan necessary medical information related to such care; and
|
|
(C) to otherwise adhere to the health care plan's
|
| policies and procedures including, but not limited to procedures regarding referrals and obtaining preauthorization for treatment.
|
|
(c) In no event shall this Section be construed to require a health care
plan
to
provide coverage for benefits not otherwise covered or to diminish or
impair preexisting condition limitations contained in the enrollee's
contract. In no event shall this Section be construed to prohibit the addition of prescription drugs to a health care plan's list of covered drugs during the coverage year.
(Source: P.A. 100-1052, eff. 8-24-18.)
|
(215 ILCS 134/45)
Sec. 45. Health care services appeals,
complaints, and
external independent reviews.
(a) A health care plan shall establish and maintain an appeals procedure as
outlined in this Act. Compliance with this Act's appeals procedures shall
satisfy a health care plan's obligation to provide appeal procedures under any
other State law or rules.
All appeals of a health care plan's administrative determinations and
complaints regarding its administrative decisions shall be handled as required
under Section 50.
(b) When an appeal concerns a decision or action by a health care plan,
its
employees, or its subcontractors that relates to (i) health care services,
including, but not limited to, procedures or
treatments,
for an enrollee with an ongoing course of treatment ordered
by a health care provider,
the denial of which could significantly
increase the risk to an
enrollee's health,
or (ii) a treatment referral, service,
procedure, or other health care service,
the denial of which could significantly
increase the risk to an
enrollee's health,
the health care plan must allow for the filing of an appeal
either orally or in writing. Upon submission of the appeal, a health care plan
must notify the party filing the appeal, as soon as possible, but in no event
more than 24 hours after the submission of the appeal, of all information
that the plan requires to evaluate the appeal.
The health care plan shall render a decision on the appeal within
24 hours after receipt of the required information. The health care plan shall
notify the party filing the
appeal and the enrollee, enrollee's primary care physician, and any health care
provider who recommended the health care service involved in the appeal of its
decision orally
followed-up by a written notice of the determination.
(c) For all appeals related to health care services including, but not
limited to, procedures or treatments for an enrollee and not covered by
subsection (b) above, the health care
plan shall establish a procedure for the filing of such appeals. Upon
submission of an appeal under this subsection, a health care plan must notify
the party filing an appeal, within 3 business days, of all information that the
plan requires to evaluate the appeal.
The health care plan shall render a decision on the appeal within 15 business
days after receipt of the required information. The health care plan shall
notify the party filing the appeal,
the enrollee, the enrollee's primary care physician, and any health care
provider
who recommended the health care service involved in the appeal orally of its
decision followed-up by a written notice of the determination.
(d) An appeal under subsection (b) or (c) may be filed by the
enrollee, the enrollee's designee or guardian, the enrollee's primary care
physician, or the enrollee's health care provider. A health care plan shall
designate a clinical peer to review
appeals, because these appeals pertain to medical or clinical matters
and such an appeal must be reviewed by an appropriate
health care professional. No one reviewing an appeal may have had any
involvement
in the initial determination that is the subject of the appeal. The written
notice of determination required under subsections (b) and (c) shall
include (i) clear and detailed reasons for the determination, (ii)
the medical or
clinical criteria for the determination, which shall be based upon sound
clinical evidence and reviewed on a periodic basis, and (iii) in the case of an
adverse determination, the
procedures for requesting an external independent review as provided by the Illinois Health Carrier External Review Act.
(e) If an appeal filed under subsection (b) or (c) is denied for a reason
including, but not limited to, the
service, procedure, or treatment is not viewed as medically necessary,
denial of specific tests or procedures, denial of referral
to specialist physicians or denial of hospitalization requests or length of
stay requests, any involved party may request an external independent review as provided by the Illinois Health Carrier External Review Act.
(f) Until July 1, 2013, if an external independent review decision made pursuant to the Illinois Health Carrier External Review Act upholds a determination adverse to the covered person, the covered person has the right to appeal the final decision to the Department; if the external review decision is found by the Director to have been arbitrary and capricious, then the Director, with consultation from a licensed medical professional, may overturn the external review decision and require the health carrier to pay for the health care service
or treatment; such decision, if any, shall be made solely on
the legal or medical merits of the claim. If an external review decision is overturned by the Director pursuant to this Section and the health carrier so requests, then the Director shall assign a new independent review organization to reconsider the overturned decision. The new independent review organization shall follow subsection (d) of Section 40 of the Health Carrier External Review Act in rendering a decision.
(g) Future contractual or employment action by the health care plan
regarding the
patient's physician or other health care provider shall not be based solely on
the physician's or other
health care provider's participation in health care services appeals,
complaints, or
external independent reviews under the Illinois Health Carrier External Review Act.
(h) Nothing in this Section shall be construed to require a health care
plan to pay for a health care service not covered under the enrollee's
certificate of coverage or policy.
(Source: P.A. 96-857, eff. 7-1-10 .)
|
(215 ILCS 134/45.1) Sec. 45.1. Medical exceptions procedures required. (a) Notwithstanding any other provision of law, on or after
January 1, 2018 (the effective date of Public Act 99-761), every insurer licensed in this State to sell a policy
of group or individual accident and health insurance or a
health benefits plan shall establish and maintain a medical exceptions process that allows covered persons or their authorized representatives to request any clinically appropriate prescription drug when (1) the drug is not covered based on the health benefit plan's formulary; (2) the health benefit plan is discontinuing coverage of the drug on the plan's formulary for reasons other than safety or other than because the prescription drug has been withdrawn from the market by the drug's manufacturer; (3) the prescription drug alternatives required to be used in accordance with a step therapy requirement (A) has been ineffective in the treatment of the enrollee's disease or medical condition or, based on both sound clinical evidence and medical and scientific evidence, the known relevant physical or mental characteristics of the enrollee, and the known characteristics of the drug regimen, is likely to be ineffective or adversely affect the drug's effectiveness or patient compliance or (B) has caused or, based on sound medical evidence, is likely to cause an adverse reaction or harm to the enrollee; or (4) the number of doses available under a dose restriction for the prescription drug (A) has been ineffective in the treatment of the enrollee's disease or medical condition or (B) based on both sound clinical evidence and medical and scientific evidence, the known relevant physical and mental characteristics of the enrollee, and known characteristics of the drug regimen, is likely to be ineffective or adversely affect the drug's effective or patient compliance. (b) The health carrier's established medical exceptions procedures must require, at a minimum, the following: (1) Any request for approval of coverage made |
| verbally or in writing (regardless of whether made using a paper or electronic form or some other writing) at any time shall be reviewed by appropriate health care professionals.
|
|
(2) The health carrier must, within 72 hours after
|
| receipt of a request made under subsection (a) of this Section, either approve or deny the request. In the case of a denial, the health carrier shall provide the covered person or the covered person's authorized representative and the covered person's prescribing provider with the reason for the denial, an alternative covered medication, if applicable, and information regarding the procedure for submitting an appeal to the denial.
|
|
(3) In the case of an expedited coverage
|
| determination, the health carrier must either approve or deny the request within 24 hours after receipt of the request. In the case of a denial, the health carrier shall provide the covered person or the covered person's authorized representative and the covered person's prescribing provider with the reason for the denial, an alternative covered medication, if applicable, and information regarding the procedure for submitting an appeal to the denial.
|
|
(c) A step therapy requirement exception request shall be
approved if:
(1) the required prescription drug is contraindicated;
(2) the patient has tried the required prescription
|
| drug while under the patient's current or previous health insurance or health benefit plan and the prescribing provider submits evidence of failure or intolerance; or
|
|
(3) the patient is stable on a prescription drug
|
| selected by his or her health care provider for the medical condition under consideration while on a current or previous health insurance or health benefit plan.
|
|
(d) Upon the granting of an exception request, the insurer,
health plan, utilization review organization, or other entity
shall authorize the coverage for the drug
prescribed by the enrollee's treating health care provider,
to the extent the prescribed drug is a covered drug under the policy or contract up to the quantity covered.
(e) Any approval of a medical exception request made pursuant to this Section shall be honored for 12 months following the date of the approval or until renewal of the plan.
(f) Notwithstanding any other provision of this Section, nothing in this Section shall be interpreted or implemented in a manner not consistent with the federal Patient Protection and Affordable Care Act (Public Law 111-148), as amended by the federal Health Care and Education Reconciliation Act of 2010 (Public Law 111-152), and any amendments thereto, or regulations or guidance issued under those Acts.
(g) Nothing in this Section shall require or authorize the State agency responsible for the administration of the medical assistance program established under the Illinois Public Aid Code to approve, supply, or cover prescription drugs pursuant to the procedure established in this Section.
(Source: P.A. 103-154, eff. 6-30-23.)
|
(215 ILCS 134/50)
Sec. 50.
Administrative complaints and Departmental review.
(a) Administrative complaint process.
(1) A health care plan shall accept and review |
| appeals of its determinations and complaints related to administrative issues initiated by enrollees or their health care providers (complainant). All appeals of a health care plan's determinations and complaints related to health care services shall be handled as required under Section 45. Nothing in this Act shall be construed to preclude an enrollee from filing a complaint with the Department or as limiting the Department's ability to investigate complaints. In addition, any enrollee not satisfied with the plan's resolution of any complaint may appeal that final plan decision to the Department.
|
|
(2) When a complaint against a health care plan
|
| (respondent) is received by the Department, the respondent shall be notified of the complaint. The Department shall, in its notification, specify the date when a report is to be received from the respondent, which shall be no later than 21 days after notification is sent to the respondent. A failure to reply by the date specified may be followed by a collect telephone call or collect telegram. Repeated instances of failing to reply by the date specified may result in further regulatory action.
|
|
(3) The respondent's report shall supply adequate
|
| documentation that explains all actions taken or not taken and that were the basis for the complaint. The report shall include documents necessary to support the respondent's position and any information requested by the Department. The respondent's reply shall be in duplicate, but duplicate copies of supporting documents shall not be required. The respondent's reply shall include the name, telephone number, and address of the individual assigned to investigate or process the complaint. The Department shall respect the confidentiality of medical reports and other documents that by law are confidential. Any other information furnished by a respondent shall be marked "confidential" if the respondent does not wish it to be released to the complainant.
|
|
(b) Departmental review. The Department shall review the plan decision to
determine
whether it is consistent with the plan and Illinois law and rules. Upon receipt
of the respondent's
report, the Department shall evaluate the material submitted and:
(1) advise the complainant of the action taken and
|
| disposition of the complaint;
|
|
(2) pursue further investigation with the respondent
|
|
(3) refer the investigation report to the appropriate
|
| branch within the Department for further regulatory action.
|
|
(c) The Department of Insurance and the Department of Public Health shall
coordinate
the complaint review and investigation process. The Department of Insurance and
the Department
of Public Health shall jointly establish rules under the Illinois
Administrative Procedure Act
implementing this complaint process.
(Source: P.A. 91-617, eff. 1-1-00.)
|
(215 ILCS 134/70)
Sec. 70. Post-stabilization medical services.
(a) If prior authorization for covered post-stabilization services is
required by the health care
plan, the plan shall provide access 24 hours a day, 7 days a week to persons
designated by
the plan to make such determinations, provided that any determination made
under this Section must be made by a health care
professional. The review shall be resolved in accordance with the provisions
of Section 85 and the time requirements of this Section.
(a-5) Prior authorization or approval by the plan shall not be required for post-stabilization services that constitute emergency services under Section 356z.3a of the Illinois Insurance Code. (b) The treating physician licensed to practice medicine in all its branches
or health care provider shall contact the health care plan or
delegated health care provider as
designated on the enrollee's health insurance card to obtain
authorization, denial, or
arrangements for an alternate plan of treatment or transfer of the
enrollee.
(c) The treating physician licensed to practice medicine in all its
branches or
health care provider shall document in the enrollee's
medical record the enrollee's
presenting symptoms; emergency medical condition; and time, phone number
dialed,
and result of the communication for request for authorization of
post-stabilization medical services. The health care plan shall provide
reimbursement for covered
post-stabilization medical services if:
(1) authorization to render them is received from the |
| health care plan or its delegated health care provider, or
|
|
(2) after 2 documented good faith efforts, the
|
| treating health care provider has attempted to contact the enrollee's health care plan or its delegated health care provider, as designated on the enrollee's health insurance card, for prior authorization of post-stabilization medical services and neither the plan nor designated persons were accessible or the authorization was not denied within 60 minutes of the request. "Two documented good faith efforts" means the health care provider has called the telephone number on the enrollee's health insurance card or other available number either 2 times or one time and an additional call to any referral number provided. "Good faith" means honesty of purpose, freedom from intention to defraud, and being faithful to one's duty or obligation. For the purpose of this Act, good faith shall be presumed.
|
|
(d) After rendering any post-stabilization medical services,
the treating physician licensed to practice medicine
in all its branches or health care
provider shall continue to make every reasonable effort to contact the health
care plan
or its delegated health care provider regarding authorization, denial, or
arrangements
for an
alternate plan of treatment or transfer of the enrollee until the
treating health care provider
receives instructions from the health care plan or delegated health care
provider for
continued care or the care is transferred to another health care provider or
the patient is discharged.
(e) Payment for covered post-stabilization services may be denied:
(1) if the treating health care provider does not
|
| meet the conditions outlined in subsection (c);
|
|
(2) upon determination that the post-stabilization
|
| services claimed were not performed;
|
|
(3) upon timely determination that the
|
| post-stabilization services rendered were contrary to the instructions of the health care plan or its delegated health care provider if contact was made between those parties prior to the service being rendered;
|
|
(4) upon determination that the patient receiving
|
| such services was not an enrollee of the health care plan; or
|
|
(5) upon material misrepresentation by the enrollee
|
| or health care provider; "material" means a fact or situation that is not merely technical in nature and results or could result in a substantial change in the situation.
|
|
(f) Nothing in this Section prohibits a health care plan from delegating
tasks associated with the responsibilities enumerated in this Section to the
health care plan's contracted health care providers or another
entity. Only a clinical peer may make an adverse determination. However, the
ultimate responsibility for
coverage and payment decisions may not be delegated.
(g) Coverage and payment for post-stabilization medical services for which
prior
authorization or deemed approval is received shall not be retrospectively
denied.
(h) Nothing in this Section shall prohibit the imposition of deductibles,
copayments, and co-insurance.
Nothing in this Section alters the prohibition on billing enrollees contained
in the Health Maintenance Organization Act.
(Source: P.A. 102-901, eff. 7-1-22.)
|
(215 ILCS 134/80)
Sec. 80. Quality assessment program.
(a) A health care plan shall develop and implement a quality assessment and
improvement strategy designed to identify and evaluate accessibility,
continuity, and quality of care. The health care plan shall have:
(1) an ongoing, written, internal quality assessment |
|
(2) specific written guidelines for monitoring and
|
| evaluating the quality and appropriateness of care and services provided to enrollees requiring the health care plan to assess:
|
|
(A) the accessibility to health care providers;
(B) appropriateness of utilization;
(C) concerns identified by the health care plan's
|
| medical or administrative staff and enrollees; and
|
|
(D) other aspects of care and service directly
|
| related to the improvement of quality of care;
|
|
(3) a procedure for remedial action to correct
|
| quality problems that have been verified in accordance with the written plan's methodology and criteria, including written procedures for taking appropriate corrective action;
|
|
(4) follow-up measures implemented to evaluate the
|
| effectiveness of the action plan.
|
|
(b) The health care plan shall establish a committee that oversees the
quality assessment and improvement strategy which includes physician
and enrollee participation.
(c) Reports on quality assessment and improvement activities shall be made
to the governing body of the health care plan not less than quarterly.
(d) The health care plan shall make available its written description of
the quality assessment program to the Department of
Public Health.
(e) With the exception of subsection (d), the Department of Public Health
shall accept evidence of accreditation with regard to the health care network
quality management and performance improvement standards of:
(1) the National Commission on Quality Assurance
|
|
(2) the American Accreditation Healthcare Commission
|
|
(3) the Joint Commission on Accreditation of
|
| Healthcare Organizations (JCAHO);
|
|
(4) the Accreditation Association for Ambulatory
|
|
(5) any other entity that the Director of Public
|
| Health deems has substantially similar or more stringent standards than provided for in this Section.
|
|
(f) If the Department of Public Health determines that a health care plan
is not in compliance with the terms of this Section, it shall certify the
finding to the Department of Insurance. The Department of Insurance shall
subject a health care plan to penalties, as provided in this Act, for such
non-compliance.
(Source: P.A. 99-111, eff. 1-1-16 .)
|
(215 ILCS 134/85)
Sec. 85. Utilization review program registration.
(a) No person may conduct a utilization review program in this State unless
once every 2 years the person
registers the utilization review program with the Department and certifies
compliance with the Health
Utilization Management Standards of the American Accreditation Healthcare
Commission (URAC) sufficient to achieve American Accreditation Healthcare
Commission (URAC) accreditation or submits evidence of accreditation by the
American
Accreditation Healthcare Commission (URAC) for its Health Utilization
Management Standards.
Nothing in this Act shall be construed to require a health care plan or its
subcontractors to become American Accreditation Healthcare Commission (URAC)
accredited.
(b) In addition, the Director of the Department, in consultation with the
Director of the Department of Public Health, may certify alternative
utilization review standards of national accreditation organizations or
entities in order for plans to comply with this Section. Any alternative
utilization review standards shall meet or exceed those standards required
under subsection (a).
(b-5) The Department shall recognize the Accreditation Association for Ambulatory Health Care among the list of accreditors from which utilization organizations may receive accreditation and qualify for reduced registration and renewal fees. (c) The provisions of this Section do not apply to:
(1) persons providing utilization review program |
| services only to the federal government;
|
|
(2) self-insured health plans under the federal
|
| Employee Retirement Income Security Act of 1974, however, this Section does apply to persons conducting a utilization review program on behalf of these health plans;
|
|
(3) hospitals and medical groups performing
|
| utilization review activities for internal purposes unless the utilization review program is conducted for another person.
|
|
Nothing in this Act prohibits a health care plan or other entity from
contractually requiring an entity designated in item (3) of this subsection
to adhere to
the
utilization review program requirements of
this Act.
(d) This registration shall include submission of all of the following
information
regarding utilization review program activities:
(1) The name, address, and telephone number of the
|
| utilization review programs.
|
|
(2) The organization and governing structure of the
|
| utilization review programs.
|
|
(3) The number of lives for which utilization review
|
| is conducted by each utilization review program.
|
|
(4) Hours of operation of each utilization review
|
|
(5) Description of the grievance process for each
|
| utilization review program.
|
|
(6) Number of covered lives for which utilization
|
| review was conducted for the previous calendar year for each utilization review program.
|
|
(7) Written policies and procedures for protecting
|
| confidential information according to applicable State and federal laws for each utilization review program.
|
|
(e) (1) A utilization review program shall have written procedures for
assuring that patient-specific information obtained during the process of
utilization review will be:
(A) kept confidential in accordance with applicable
|
| State and federal laws; and
|
|
(B) shared only with the enrollee, the enrollee's
|
| designee, the enrollee's health care provider, and those who are authorized by law to receive the information.
|
|
Summary data shall not be considered confidential if it does not provide
information to allow identification of individual patients or health care
providers.
(2) Only a health care professional may make
|
| determinations regarding the medical necessity of health care services during the course of utilization review.
|
|
(3) When making retrospective reviews, utilization
|
| review programs shall base reviews solely on the medical information available to the attending physician or ordering provider at the time the health care services were provided.
|
|
(4) When making prospective, concurrent, and
|
| retrospective determinations, utilization review programs shall collect only information that is necessary to make the determination and shall not routinely require health care providers to numerically code diagnoses or procedures to be considered for certification, unless required under State or federal Medicare or Medicaid rules or regulations, but may request such code if available, or routinely request copies of medical records of all enrollees reviewed. During prospective or concurrent review, copies of medical records shall only be required when necessary to verify that the health care services subject to review are medically necessary. In these cases, only the necessary or relevant sections of the medical record shall be required.
|
|
(f) If the Department finds that a utilization review program is
not in compliance with this Section, the Department shall issue a corrective
action plan and allow a reasonable amount of time for compliance with the plan.
If the utilization review program does not come into compliance, the
Department may issue a cease and desist order. Before issuing a cease and
desist order under this Section, the Department shall provide the
utilization review program with a written notice of the reasons for the
order and allow a reasonable amount of time to supply additional information
demonstrating compliance with requirements of this Section and to request a
hearing. The hearing notice shall be sent by certified mail, return receipt
requested, and the hearing shall be conducted in accordance with the Illinois
Administrative Procedure Act.
(g) A utilization review program subject to a corrective action may continue
to conduct business
until a final decision has been issued by the Department.
(h) Any adverse determination made by a health care plan or its
subcontractors may be appealed
in accordance with subsection (f) of Section 45.
(i) The Director may by rule establish a registration fee for each person
conducting a utilization review program. All fees paid to and collected by the
Director under this Section shall be deposited into
the Insurance Producer Administration Fund.
(Source: P.A. 99-111, eff. 1-1-16 .)
|
(215 ILCS 134/90)
Sec. 90.
Office of Consumer Health Insurance.
(a) The Director of Insurance shall establish the Office of Consumer
Health Insurance within the Department of Insurance to provide assistance and
information to all health care consumers within the State. Within the
appropriation allocated, the Office shall provide information and assistance to
all health care consumers by:
(1) assisting consumers in understanding health |
| insurance marketing materials and the coverage provisions of individual plans;
|
|
(2) educating enrollees about their rights within
|
|
(3) assisting enrollees with the process of filing
|
| formal grievances and appeals;
|
|
(4) establishing and operating a toll-free "800"
|
| telephone number line to handle consumer inquiries;
|
|
(5) making related information available in languages
|
| other than English that are spoken as a primary language by a significant portion of the State's population, as determined by the Department;
|
|
(6) analyzing, commenting on, monitoring, and making
|
| publicly available reports on the development and implementation of federal, State, and local laws, regulations, and other governmental policies and actions that pertain to the adequacy of health care plans, facilities, and services in the State;
|
|
(7) filing an annual report with the Governor, the
|
| Director, and the General Assembly, which shall contain recommendations for improvement of the regulation of health insurance plans, including recommendations on improving health care consumer assistance and patterns, abuses, and progress that it has identified from its interaction with health care consumers; and
|
|
(8) performing all duties assigned to the Office by
|
|
(b) The report required under subsection (a)(7) shall be filed by January
31, 2001 and each January 31 thereafter.
(c) Nothing in this Section shall be interpreted to authorize access to or
disclosure of individual patient or health care professional or provider
records.
(Source: P.A. 91-617, eff. 1-1-00.)
|